[Hemopurification in sepsis: current view]
- PMID: 19009768
[Hemopurification in sepsis: current view]
Abstract
Sepsis is the leading cause of mortality in non-coronary intensive care units. The uncontrolled and deregulated systemic inflammatory response to infection plays a central role in the pathophysiology of sepsis. This response is mediated by a broad spectrum of endogenous mediators leading to dysfunction in multiple organs remote from the primary infectious site. The failure of numerous clinical trials aimed at eliminating a single mediator stimulated the research to focus on non-selective removal of excessively produced mediators of sepsis. This "detoxification" forms the theoretical basis and biological rationale for the use of hemopurification therapies as an adjunctive treatment of sepsis. Our article reviews the current evidence of hemopurification methods in the supportive treatment of sepsis, briefly discusses new trends and summarizes the recommendations for clinical practice.
Similar articles
-
Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing.J Crit Care. 2007 Mar;22(1):1-12. doi: 10.1016/j.jcrc.2006.05.002. Epub 2007 Jan 31. J Crit Care. 2007. PMID: 17371737 Review.
-
[Hemofiltration during severe sepsis or multiorgan failure syndrome].Nephrologie. 1998;19(2):83-8. Nephrologie. 1998. PMID: 9592778 Review. French.
-
[The role of elective hemofiltration in the management of sepsis and multiple organ failure].Orv Hetil. 1998 May 17;139(20):1229-33. Orv Hetil. 1998. PMID: 9619044 Review. Hungarian.
-
Present and future options in continuous renal replacement therapies of sepsis and MOF.Minerva Anestesiol. 1999 Jun;65(6):419-26. Minerva Anestesiol. 1999. PMID: 10394813 Review.
-
[Hemopurification in the management of ARDS complicating multiple organ failure].Nihon Kyobu Shikkan Gakkai Zasshi. 1991 Feb;29(2):170-4. Nihon Kyobu Shikkan Gakkai Zasshi. 1991. PMID: 1903467 Japanese.
Publication types
MeSH terms
LinkOut - more resources
Medical